The members of the CareAcross Scientific Committee are internationally acknowledged experts in Oncology. We are proud and thankful for their support.

 

Europe

Adamos Adamou
Member of the Emerging Countries Committee at the European Society for Medical Oncology (ESMO).
Member of the Cypriot House of Parliament. Former member of the European Parliament.

Jean-Pierre Armand
Institut Gustave Roussy, Villejuif, France.
Past President of the European Society for Medical Oncology (ESMO).
Expert in early drug development.

Katia Boleti
Medical Oncologist, Royal Free Hospital, London, United Kingdom.
Expert in renal cell carcinoma.

Federico Cappuzzo
Director of the Medical Oncology Department at the Ospedale Civile - Istituto Toscano Tumori, Livorno, Italy.
Expert in personalized treatment for lung cancer.

Paolo Casali
Head of the Adult Mesenchymal Tumour Medical Oncology Unit, Istituto Nazionale Tumori, Milan, Italy.
Member of the European Society for Medical Oncology (ESMO) Executive Board. Chairman of the ESMO Public Policy Committee. Former ESMO Treasurer.
Editor in Chief of the Clinical Sarcoma Research journal.
Expert in sarcomas.

Raphael Catane
Chaim Sheba Medical Center, Ramat Gan, Israel.
Professor & Chairman, Division of Oncology, Tel Hashomer Campus, Tel Aviv University, Israel.
Founding member of the Palliative Care Group of the European Society for Medical Oncology (ESMO).
Expert in palliative and supportive care.

Fortunato Ciardiello
Full Professor of Medical Oncology, Seconda Università di Napoli in Naples, Italy.
President-Elect of the European Society for Medical Oncology (ESMO).
Expert in personalized oncology.

Mario Dicato
Centre Hospitalier de Luxembourg, Luxembourg.
Founder, and Head of the Research Laboratory, of the Luxembourg Foundation for Research on Cancer and Blood Disorders.
Co-Chairman of the ESMO World Congress on Gastrointestinal Cancer.

Alexandru Eniu
Ion Chiricuta Oncology Institute-IOCN, Cluj Napoca, Romania.
Member of the Executive Board at the European Society for Medical Oncology (ESMO), Chairman of the ESMO Emerging Countries Committee.

Enriqueta Felip
Head, Lung Cancer Unit, Oncology Department at Vall d'Hebron University, Barcelona, Spain.
Member of the editorial board of the Guidelines Working Group at the European Society for Medical Oncology (ESMO).
Editor-in-chief of Cancer & Chemotherapy Reviews, Associated Editor of the Spanish edition of Journal of Clinical Oncology, Associated Editor of Annals of Oncology.
Expert in lung cancer.

David Kerr
Professor of Cancer Medicine, University of Oxford. Adjunct Professor of Medicine, Weill-Cornell College of Medicine, New York.
Past President of the European Society for Medical Oncology (ESMO).
Active in colon cancer research.
Founder of the Africa Oxford Cancer Foundation.

Roberto Labianca
Head, Medical Oncology Unit at the Ospedali Riuniti di Bergamo, Italy.
Gastrointestinal cancer expert.
Chairman of the Medical Oncology Status in Europe Survey program.

Heinz Ludwig
Wilhelminenspital, Vienna, Austria.
Past President of the European Society for Medical Oncology (ESMO).
Expert in multiple myeloma and treating anemia.

Håkan Mellstedt
Karolinska University Hospital and Karolinska Institute-Huddinge, Stockholm, Sweden.
Past President of the European Society for Medical Oncology (ESMO).
Expert in cancer immunotherapy.
Co-founder of Kancera AB.

Razvan Popescu
Head of Medical Oncology and Co-Chair of the Tumor Centre in the Hirslanden Clinic in Aarau, Switzerland.
ESMO (European Society for Medical Oncology) Executive Board Member.
Areas of interest include gastrointestinal cancer as well as elderly, supportive and palliative care.

Rafael Rosell
Director, Cancer Biology & Precision Medicine Program, Catalan Institute of Oncology, Hospital Germans Trias i Pujol, Badalona, Spain.
Expert in personalized treatment in lung cancer.

Hans-Joachim Schmoll
Head of the Department of Oncology and Hematology, University of Halle, Germany.
Associate Professor of Internal Medicine, and Hematology/Oncology, Hemostaseology, University of Halle, Germany.
Editor in chief of online oncology journal OncoTargets & Therapy.
Expert in gastrointestinal cancer & testicular cancer.

Jean-Charles Soria
Chair of Drug Development Department at Gustave Roussy Cancer Center in Paris. Adjunct Professor at the University of Texas MD Anderson Cancer Center.
Professor of Medicine and Medical Oncology at South-Paris University.
Editor in chief of Annals of Oncology journal.
Expert in personalized medicine, specialized in lung cancer.

Rolf Stahel
Clinic and Policlinic for Oncology, University of Zürich.
Professor of Medicine at the University of Zürich.
President of the European Society for Medical Oncology (ESMO). President of the European Thoracic Oncology Platform (ETOP). Founding member and first president of the Swiss Society for Medical Oncology.
Editor in-chief of Lung Cancer journal, and editor of Cancer Treatment Reviews and Progress in Tumour Research journal.
Expert in chest tumors.

Christoph Zielinski
Professor at the Department of Medicine, and Director of the Clinical Division of Oncology and Chairman of the Department of Medicine, at Medical University Vienna, Austria.
President of the Central European Cooperative Oncology Group (CECOG).

 

America

George Canellos
Dana Farber Cancer Institute, Boston, United States of America.
Professor of Medicine, Harvard Medical School.
Past President of the American Society of Clinical Oncology (ASCO).
Expert in lymphomas.

Eduardo Cazap
Latinamerican & Caribbean Society for Medical Oncolgy (SLACOM), Buenos Aires, Argentina.
Founder and first President of the Latinamerican & Caribbean Society of Medical Oncology (SLACOM). Past President of Union for International Cancer Control (UICC).

George Demetri
Director, Center for Sarcoma and Bone Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, United States of America.
Professor, Department of Medicine, Harvard Medical School.
Expert in sarcomas.

Christopher Logothetis
The University of Texas MD Anderson Cancer Center, Houston, TX, United States of America.
Professor, Department Chair, Department of Genitourinary Medical Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Expert in uro-oncology (bladder, prostate and testicular cancer).

 

Asia

Tony Mok
Professor in the Department of Clinical Oncology at the Chinese University of Hong Kong in Prince of Wales Hospital in Hong Kong.
President of the International Association for the Study of Lung Cancer (IASLC), Vice-Secretary General of the Chinese Society of Clinical Oncology (CSCO).
Specialist in targeted treatment for lung cancer.

Haluk Onat
Anadolu Medical Center Hospital, Gebze, Turkey.
Founder fellow and President of Turkish Medical Oncology Society.

Purvish Parikh
Indian Cooperative Oncology Network, Mumbai, India.
President of the Indian Society of Medical & Pediatric Oncology.

Nagahiro Saijo
Japanese Society of Medical Oncology, Tokyo, Japan.
Founding President of the Japanese Society of Medical Oncology. Former President of International Association for the Study of Lung Cancer (IASLC).
Member of The ASCO Post's International Editorial Advisory Board.

 

Africa

Daniel Vorobiof
Sandton Oncology Centre, Sandton, South Africa.
Founder member and past Chairman of South African Society of Medical Oncology (SASMO). Past Chairman of the South African Melanoma Advisory Board. Founder member of the International Oncology Foundation (IOF). Founder member and past director of the South African Oncology Consortium.
Member of The ASCO Post’s International Editorial Board.

 

Australia

Nico van Zandwijk
Director, Asbestos Diseases Research Institute.
Professor of Medicine, University of Sydney.
Active member of the International Association for the Study of Lung Cancer (IASLC). Active member of the EORTC Lung Cancer Cooperative Group.
Expert in chest tumors.